Feed
Search
Sign in
Company
CLNN
Nasdaq
Salt Lake City, UT
Clene Inc.
Clene Inc.
Stories only
SEC EDGAR
ClinicalTrials.gov
clene.com
3
Stories in coverage
0
Programs
0
Registered trials
8-K
Sep 16
Latest SEC filing, period to Sep 15
Sep 16
Latest story
Timeline
3
Pipeline
0
Trials
0
All
3
Filings and people
3
September 2026
Clene prices $4 million registered direct offering with insider participation
Sep 16
People
Clene Inc.
Clene sells $4 million in stock directly to insiders and existing holders
Sep 16
Financing
Clene Inc.
August 2026
Clene reports Q2 2026 results, plans ALS drug filing for early Q4
Aug 14
Quarterly update
Clene Inc.